drugset / Trial / NCT06655324
A Study to Evaluate Safety, Tolerability, and Immunogenicity of V350A and V350B in Healthy Participants (V350-001).
RandomizedSequentialTriple-blindBasic science
Summary
Epstein Barr virus (EBV) is a virus which can cause infectious mononucleosis and is associated with certain kinds of cancer and multiple sclerosis. Researchers are looking for new ways to prevent disease related to EBV and have developed a new study vaccine (V350A and V350B). The main goal of this study is to learn about the safety and tolerability of V350A and V350B in healthy adults.
Timeline
- Start
- 2024-12-05
- Primary completion
- 2028-07-17
- Completion
- 2028-07-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | V350A | Vaccine | — | Intramuscular |
| Subject | V350B | Vaccine | — | Intramuscular |
Indications
No indication recorded.